spacer spacer spacer

Board of Trustees


The Honorable Louis W. Sullivan, MD, Chairman
President Emeritus, Morehouse School of Medicine

Louis Sullivan has served as the Museum's Chairman since 2003. His distinguished career includes service as U.S. Secretary of Health and Human Services from 1989 to 1993, prior to and following which he was President of Morehouse School of Medicine, which he now serves as President Emeritus. He served as co-chair of the President's Commission on HIV and AIDS from 2001-2006, and was chair of the President's Commission on Historically Black Colleges and Universities from 2002-2009. A graduate of Morehouse College, he earned his medical degree from Boston University, and is certified in internal medicine and hematology. The recipient of 45 honorary degrees, he served on the faculties of the medical schools at Harvard, Seton Hall, and Boston universities before arriving at Morehouse in 1975. He was also the founding president of the Association of Minority Health Professions Schools.

G. Steven Burrill, Vice Chairman
Chief Executive Officer, Burrill & Company

Steve Burrill is the CEO of Burrill & Company, a San Francisco-based private merchant bank focused exclusively on life science companies. Burrill & Company revolves around several core activities -- strategic partnering, spinouts, venture capital investment, and media - and has over $950 million under management. Prior to founding Burrill & Company, Mr. Burrill spent 28 years with Ernst & Young, directing and coordinating services to clients in the biotechnology/life sciences and high technology industries worldwide. He was also International Chairman of their Manufacturing/High Technology practice. In 2002, he was recognized as the biotech investment visionary by Scientific American magazine (The Scientific American 50). A strong proponent of informal science education, Mr. Burrill is an internationally recognized spokesman for the life sciences and technology industries.

Michael M.E. Johns, MD, Vice Chairman
Chancellor, Emory University

Michael Johns became Chancellor for Emory University in October, 2007. Previously he served as Executive Vice President for Health Affairs; CEO, The Robert W. Woodruff Health Sciences Center; Chairman of the Board, Emory Healthcare; Co-Chairman of the Board, EHCA, LLC; and Professor of Otolaryngology, Emory University School of Medicine. Over the course of 11 years, he engineered the transformation of Emory University's Health Sciences Center into one of the nation's preeminent centers in education, research, and patient care. Prior to joining Emory, Dr. Johns was Dean of the Johns Hopkins School of Medicine and Vice President of the Medical Faculty. He is a member of the Institute of Medicine (IOM) and serves on a variety of private-sector and philanthropic boards, including Johnson & Johnson and the Georgia Cancer Coalition. Dr. Johns received his bachelor's degree from Wayne State University and his medical degree from the University of Michigan Medical School.

Chairman Emeritus

C. Everett Koop, MD, ScD, Chairman Emeritus
C. Everett Koop Institute at Dartmouth

Dr. Koop served as U.S. Surgeon General from 1981 to 1989. In this role he oversaw the activities of the 6,000 member PHS Commissioned Corps and advised the public on a variety of health matters including smoking and health, diet and nutrition, immunization and HIV/AIDS. Dr. Koop continues to be a force for public health and education through his writings and public appearances, and as Senior Scholar of the C. Everett Koop Institute at Dartmouth. He served as Chairman of the National Health Museum from 1990 to 2000, when he became Chairman Emeritus.


Joel Babbit
Chief Executive Officer and co-founder, Mother Nature Network

Joel Babbit launched the environmental news site Mother Nature Network in 2009 after more than twenty years in the advertising and public relations industry where he created two of the largest and most awarded advertising agencies in the Southeast - Babbit and Reiman (acquired by London-based GGT) and 360 (acquired by Grey Global Group). He also served as President of GCI, which was one of the world's 10 largest public relations firms with 40 offices in 22 countries. His clients have included The Home Depot, Coca-Cola, Dell, USA Today, American Express, Holiday Inn, UPS, and Citigroup. An Atlanta native, he served as the City's Chief Marketing & Communications Officer when it hosted the 1996 Olympics. Mr. Babbit has been widely honored for his work and civic contributions and was chosen Georgia Citizen of the Year in 1997.

David R. Bellaire
Partner, Bain & Company

Dave Bellaire is a Bain & Company Director and senior partner who focuses his efforts in the healthcare sector. Over a 30-year management career, he has counseled a wide array of health-related companies on issues including corporate and business unit strategy, product launch, and merger/integration. Prior to Bain, he served as Executive Vice President for health solutions, pharmaceutical services, and medical benefit operations at NDC Health, a network services company; and a lead partner and Vice President at Booz Allen Hamilton. Bellaire started, built, and sold Canada Prosthetics. He received an MBA from Northwestern University, where he also earned a graduate degree in prosthetics/bioengineering, served on the faculty of the medical school, and was a Northwestern, National Science Foundation, and Kellogg Foundation Fellow.

The Honorable Joseph A. Califano, Jr.
Chairman and President, The National Center on Addiction and Substance Abuse at Columbia University

Joseph Califano is a lawyer, public health policy educator, and writer. Mr. Califano served as U.S. Secretary of Health, Education and Welfare from 1977 through 1979. Most recently he founded and serves as Chairman and President of the Center on Addiction and Substance Abuse at Columbia University (CASA). CASA is an independent non-profit research center that brings together under one roof all the professional disciplines needed to study and combat all types of substance abuse as they affect all aspects of society.

Peter W. Carmel, MD
American Medical Association

Peter Carmel, a pediatric neurosurgeon, became the 166th president of the American Medical Association (AMA) in June 2011. Dr. Carmel has been a member of the AMA Board of Trustees since 2002 and a member of the AMA House of Delegates since 1985. Dr. Carmel is currently chairman of the Department of Neurological Surgery at the New Jersey Medical School and co-medical director of the Neurological Institute of New Jersey. He completed his medical training at the New York University School of Medicine, his residency in neurosurgery at the Neurological Institute of New York, and received his doctorate in neuroanatomy from the Columbia University College of Physicians and Surgeons. A noted clinician who operates at University Hospital in Newark, he has served in numerous positions in both the American Association of Neurological Surgeons and Congress of Neurological Surgeons.

Fuad El-Hibri
President, Emergent Biosolutions

Fuad El-Hibri is the President, Chief Executive Officer and Chairman of the Board of Directors of Emergent Biosolutions, a Maryland-based biotechnology company that develops and manufactures vaccines and therapeutics targeting infectious diseases, oncology and autoimmune disorders. The firm's product line includes BioThrax, the only FDA-licensed vaccine available for pre-exposure protection against anthrax infection. Mr. El-Hibri has also served as chairman of East West Resources Corporation, a venture capital and financial consulting firm, and as chairman of Digicel Holdings, Ltd., a privately held telecommunications firm. He is a member of the board of trustees of American University and a member of the board of directors of the International Biomedical Research Alliance, an academic joint venture among the NIH, Oxford University and Cambridge University. He also serves as chairman of the El-Hibri Charitable Foundation. Mr. El-Hibri received a master's degree in public and private management from Yale University and a B.A. in economics from Stanford University.

R. Jackson Kelly
Vice President, The Coca-Cola Company

R. Jackson Kelly is a vice president and Director of Investor Relations for Coca-Cola. He previously served as special assistant to the Office of the President and CEO, Muhtar Kent, and as a vice president in several areas of the company including international marketing, marketing operations, and business development. Other Coca-Cola brand and product experience includes roles with a number of brands include Fresca, Diet Sprite, Minute Maid, and Powerade. He also served as General Manager of the World of Coca-Cola. In addition to Coca-Cola, he has been a principal in an Atlanta based software technology company, and a Senior Accountant with Arthur Andersen. Mr. Kelly is a CPA and holds a Masters Degree in Marketing Management from Duke University and a Bachelor of Science degree from Washington and Lee University. He is actively involved as a board member of several Atlanta community organizations and is currently Board Chairman of The Atlanta Botanical Garden.

William H. Kitchens
Partner, Arnall Golden Gregory LLP

William Kitchens is a partner in the law firm of Arnall Golden Gregory LLP, and chairman of the Firm's Healthcare and Life Sciences Practice Group. He served as the Firm's Managing Partner from 1996 to 2008. He practices in the areas of food and drug law and healthcare regulatory compliance and his current practice includes representing large, medium, and small food manufacturers, medical device, pharmaceutical, and biotechnology companies. Mr. Kitchens has extensive experience representing clients in federal and state courts and before the FDA, the Drug Enforcement Administration, the US Department of Agriculture, the Federal Trade Commission, and the Environmental Protection Agency. A graduate of Emory University and the University of Georgia School of Law, he is also an Adjunct Professor at Emory University School of Law, where he has taught a course in Food and Drug Law since 1979. Mr. Kitchens has been honored by inclusion in The Best Lawyers in America and has published numerous books and articles on food and drug law and regulatory law topics and spoken widely on the subjects.

Mike Magee, MD
President, Positive Medicine, Inc.

Mike Magee is President of Positive Medicine, Inc., a strategic health communications firm, and Senior Fellow for Health Policy at the Center for Aging Services Technologies at Leading Age. He is also Editor of and Dr. Magee is a member of the National Commission for Quality Long Term Care. He has served formerly as a Senior Fellow in the Humanities to the World Medical Association; a David Rockefeller Fellow; Professor of Surgery at Jefferson Medical College; Honorary Master Scholar at New York University School of Medicine; and Vice President of Global Medical Relations and Science Policy, Pfizer, Inc.

Russell M. Medford, MD, PhD
President and Chief Executive Officer of Salutria Pharmaceuticals

Dr. Medford serves as President and CEO of Salutria, Inc., an Atlanta-based pharmaceutical company. He is a director of Inhibitex, Inc., an inaugural Fellow of the Council on Basic Cardiovascular Sciences of the American Heart Association and a past member of the Advisory Council of the National Heart, Lung and Blood Institute. He serves on the Biotechnology Industry Organization's (BIO) Board of Directors and the Emerging Companies Section Governing Body. He was an Associate Professor of Medicine and Director of Molecular Cardiology at the Emory University School of Medicine, where he currently holds the appointment of Adjunct Clinical Professor of Medicine. A molecular cardiologist whose research has focused on the molecular basis of cardiovascular disease, he has published widely in the field of molecular cardiology and holds 14 U.S. patents.

Afaf I. Meleis, PhD, FAAN
Dean of Nursing, University of Pennsylvania School of Nursing

Afaf I. Meleis, a nurse and medical sociologist, is the Margaret Bond Simon Dean of Nursing at the University of Pennsylvania School of Nursing and Council General of the International Council on Women's Health Issues. Dr. Meleis' main teaching areas are theoretical nursing, coping and living with transitions, and international health. Her scholarship is focused on theory and knowledge development, immigrant and international health, and women's role integration and health. An internationally recognized leader in nursing and global health, Dr. Meleis is an active member of the American Academy of Nursing.

James M. Phillips
Chairman/CEO, NanoMech

James M. Phillips is Chairman/CEO of NanoMech, an award-winning, innovative business based in Springdale, Arkansas, that uses nanotechnology to manufacture products with broad applications, including machining and manufacturing, lubrication and energy, and biomedical implant coatings. Mr. Phillips has enjoyed an outstanding career starting companies and guiding them through successful IPO's while bringing new technologies into industry-leading positions - including the PDA, digital cell phone, fixed cellular and internet multimedia. His career began at Nortel, which was followed by SkyTel, Motorola, and IPIX. He was recruited by FedEx to build the FedEx Institute of Technology (FIT), and became CEO in residence at Morgan Keegan, a Memphis-based investment firm, where he evaluated a technology called VeinViewer which led to the creation of Luminetix Corporation. Mr. Phillips holds a number of patents in cell phone, PDA and data modem designs, and serves on a number of non-profit boards. Other affiliations include serving on the Executive Committee of the Council on Competiveness, as a member of the U.S. Technology Leadership Council, and as a Board Member with Blue Cross Blue Shield of Tennessee.

Parker H. "Pete" Petit
Chairman and Chief Executive Officer, MiMedx Group, Inc., and President,The Petit Group

Pete Petit is Chairman and CEO of MiMedx Group, Inc., an emerging biomaterials company. He also heads The Petit Group, an Atlanta-based investment management organization. Mr. Petit was previously Chairman and CEO of Matria Healthcare, a leading provider of comprehensive disease management programs for women's health and diabetes and respiratory disorders, which was sold to Inverness Medical Innovations in 2008. He received his Bachelor's degree in Mechanical Engineering and Master of Science degree in Engineering Mechanics from Georgia Institute of Technology, and an MBA degree in Finance from Georgia State University. At Georgia Tech, Mr. Petit has funded a professorial chair for Engineering in Medicine, endowed the Petit Institute for Bioengineering and Bioscience, and assisted with the funding of the Biotechnology Building which bears his name. At Georgia State, he assisted with the funding of the Science Center building which also bears his name. A widely respected technology entrepreneur and philanthropist, he was a 1994 inductee into the Technology Hall of Fame of Georgia.

John P. Richard
Partner, Georgia Venture Partners

John Richard is a founding Partner of Georgia Venture Partners. He is also a strategic and commercial development advisor to the biotechnology industry and is currently Non-Executive Director of Phase4 Ventures in London and strategic business advisor to Agennix AG in Germany and Albireo AB in Sweden. Mr. Richard was previously Executive Vice President, Business Development, at SEQUUS Pharmaceuticals, where he was responsible for negotiating the acquisition of SEQUUS by ALZA Corporation in 1999. Prior to SEQUUS, he headed business development for VIVUS and Genome Therapeutics Corporation and was responsible for establishing numerous pharmaceutical alliances. In 1987 he co-founded and served as original CEO of IMPATH Inc., a leading commercial cancer pathology reference laboratory acquired by Genzyme. He serves on the boards of several biotechnology companies including Targacept (NASDAQ: TRGT). Mr. Richard received his M.B.A. from Harvard Business School and his B.S. from Stanford University.

Ralph Snyderman, MD
Chancellor Emeritus, Duke University
James B. Duke Professor of Medicine, Duke University School of Medicine

Ralph Snyderman became Chancellor Emeritus of Duke University in 2004. He previously served as Chancellor for Health Affairs and Dean of the School of Medicine at Duke, where he oversaw the development of the Duke University Health System into one of the most successful integrated academic health systems in the country. After stepping down as Chancellor, Dr. Snyderman founded Proventys, Inc. Dr. Snyderman is internationally recognized for his contributions in inflammation research and has received numerous honors, including the CIBA GEIGY Award, the Bonazinga Award, and the Lifetime Achievement Award from the Arthritis Foundation.

The Honorable Tommy G. Thompson
Partner, Akin Gump Strauss Hauer & Feld LLP

Tommy Thompson served as U.S. Secretary of Health and Human Services from 2001 until 2005. Prior to becoming HHS Secretary, he served an unprecedented four terms as Governor of Wisconsin and is a former chairman of the National Governors' Association. He is currently a partner with the law firm of Akin Gump Strauss Hauer & Feld LLP where he focuses on developing solutions for clients in the health care industry, and companies doing business in the public sector. Secretary Thompson is well-known for his contributions to the U.S. response to the threat of bioterrorism and for his leadership in the fight against HIV/AIDS in the United States and abroad, and he is chairman emeritus of the Global Fund to Fight AIDS, Tuberculosis and Malaria. He has received numerous awards for his public service, including the Anti-Defamation League's Distinguished Public Service Award, Governing Magazine's Public Official of the Year Award, and the Horatio Alger Award. Both his B.S. and J.D. degrees were received from the University of Wisconsin-Madison.


David H. Roland

David Roland has directed the Museum's operations and programs since 2004 and was named President/CEO in 2009. He has more than thirty-five years of management experience in life science communications and during that time has worked closely with and represented many of the nation's leading health and medical organizations. Prior to joining NHM he founded and headed The Roland Company of Reston, Virginia, a digital media services company. Previously he was president of the health communications firm Science and Medicine Enterprises; Executive Vice President at The Blackwell Corporation of Washington, Vice President at WQED-TV/FM Pittsburgh; and Vice President and General Manager at WQLN-TV/FM in Erie, Pennsylvania. A former newspaper reporter and magazine editor who was a Navy public affairs officer during the Vietnam War, David is an award-winning television and book producer and twice served as Chairman of the George Foster Peabody Awards, electronic media's highest honor. He is a graduate of Edinboro University in Pennsylvania, holds a master's degree in journalism from Ohio University, and completed a Harvard advanced management program.
Search NHM
Join the NHM Mailing List